HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹36 Cr | ₹52 Cr | ₹73 Cr | ₹56 Cr | ₹59 Cr |
What is the latest Total Non-Current Liabilities ratio of HALEOS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹59 Cr |
How is Total Non-Current Liabilities of HALEOS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | -31.43 | |
| Mar2024 | ₹52 Cr | -28.43 | |
| Mar2023 | ₹73 Cr | 29.68 | |
| Mar2022 | ₹56 Cr | -4.45 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Non-Current Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹449.2 Cr | 0.8% | -1.6% | 21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 0.8% |
-1.6% |
21% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses